Cleveland BioLabs
CBLI
#9801
Rank
S$63.58 M
Marketcap
S$4.11
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: S$63.58 Million

As of December 2025 Cleveland BioLabs has a market cap of S$63.58 Million. This makes Cleveland BioLabs the world's 9801th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022S$65.78 M-0.84%
2021S$66.33 M11.66%
2020S$59.4 M547.88%
2019S$9.16 M-41.18%
2018S$15.58 M-74.23%
2017S$60.49 M167.92%
2016S$22.58 M-58.37%
2015S$54.24 M151.97%
2014S$21.52 M-67.86%
2013S$66.97 M-7.94%
2012S$72.75 M-44.69%
2011S$0.13 B-51.16%
2010S$0.26 B186.87%
2009S$93.88 M125.04%
2008S$41.71 M-74.46%
2007S$0.16 B78.72%
2006S$91.39 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
S$27.09 M-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
S$1.37 B 2,067.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$230.20 B 361,926.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$328.62 B 516,707.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
S$137.57 B 216,261.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$156.67 B 246,289.98%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
S$126.63 B 199,048.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
S$21.04 M-66.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.173 T 1,845,699.95%๐Ÿ‡บ๐Ÿ‡ธ USA